相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biologics-induced autoimmune diseases
Roberto Perez-Alvarez et al.
CURRENT OPINION IN RHEUMATOLOGY (2013)
Role of cellular oxidative stress and cytochrome c in the pathogenesis of psoriasis
Sami A. Gabr et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2012)
Effect of biologic therapies targeting tumour necrosis factor-α on cutaneous mesenchymal stem cells in psoriasis
A. Campanati et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
New insights of T cells in the pathogenesis of psoriasis
Yihua Cai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
SIRT1 modulates MAPK pathways in ischemic-reperfused cardiomyocytes
Matteo Becatti et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Update upon efficacy and safety of TNF-alpha inhibitors
Giuseppe Murdaca et al.
EXPERT OPINION ON DRUG SAFETY (2012)
The roles of cells and cytokines in the pathogenesis of psoriasis
Susana Coimbra et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2012)
Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases
Ivan Guerra et al.
JOURNAL OF CROHNS & COLITIS (2012)
Biologic Therapy in Psoriasis: Perspectives on Associated Risks and Patient Management
Kim A. Papp et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2012)
Determination of Lymphotoxin-Alpha Levels in Patients with Psoriatic Arthritis Undergoing Etanercept Treatment
Giuseppe Murdaca et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2012)
Anti-inflammatory and antioxidant effects of infliximab on acute lung injury in a rat model of intestinal ischemia/reperfusion
Ahmet Guzel et al.
JOURNAL OF MOLECULAR HISTOLOGY (2012)
Interaction of TNF with Angiotensin II Contributes to Mitochondrial Oxidative Stress and Cardiac Damage in Rats
Nithya Mariappan et al.
PLOS ONE (2012)
Effect of Biologic Agents on Non-PASI Outcomes in Moderate-to-Severe Plaque Psoriasis: Systematic Review and Meta-Analyses
Erica L. Baker et al.
DERMATOLOGY AND THERAPY (2012)
Infliximab in Psoriatic Arthritis
Fabrizio Cantini et al.
JOURNAL OF RHEUMATOLOGY (2012)
Emerging biological drugs: A new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events
Giuseppe Murdaca et al.
AUTOIMMUNITY REVIEWS (2011)
Anti-TNF therapy
Nishanthi Thalayasingam et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2011)
Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
R. Gniadecki et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Management of Recurrent Cutaneous Abscesses During Therapy With Infliximab
Clara De Simone et al.
CLINICAL THERAPEUTICS (2011)
Worsening of Vitiligo and Onset of New Psoriasiform Dermatitis following Treatment with Infliximab
Khalid M. AlGhamdi et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2011)
ADALIMUMAB FOR THE TREATMENT OF IMMUNE-MEDIATED DISEASES: AN UPDATE ON OLD AND RECENT INDICATIONS
G. Murdaca et al.
DRUGS OF TODAY (2011)
Anti-Tumor Necrosis Factor-alpha Treatment with Infliximab for Disseminated Granuloma Annulare
Giuseppe Murdaca et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2010)
The Involvement of Smac/DIABLO, p53, NF-kB, and MAPK Pathways in Apoptosis of Keratinocytes from Perilesional Vitiligo Skin: Protective Effects of Curcumin and Capsaicin
Matteo Becatti et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
TNF-α induces mitochondrial dysfunction in 3T3-L1 adipocytes
Xiao-Hui Chen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
The Future of Biological Therapies
Richard B. Warren et al.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2010)
Role of Oxidative Stress in Various Stages of Psoriasis
Dipali P. Kadam et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2010)
Oxidative stress in the pathogenesis of psoriasis
Qiang Zhou et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
ANTI-TNF-α INHIBITORS: A NEW THERAPEUTIC APPROACH FOR INFLAMMATORY IMMUNE-MEDIATED DISEASES: AN UPDATE UPON EFFICACY AND ADVERSE EVENTS
G. Murdaca et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2009)
Expression of NADPH oxidases and enhanced H2O2-generating activity in human coronary artery endothelial cells upon induction with tumor necrosis factor-α
Lucia S. Yoshida et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death
You-Sun Kim et al.
MOLECULAR CELL (2007)
Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging
Anna Csiszar et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-alpha in human aortic smooth muscle and embryonic kidney cells
K. T. Moe et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2006)
Emerging biologic drugs for the treatment of rheumatoid arthritis
F Puppo et al.
AUTOIMMUNITY REVIEWS (2005)
Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease
P Rocha-Pereira et al.
CLINICA CHIMICA ACTA (2001)
分享论文
